Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy
Clinical trial NCT05007262 · UNKNOWN
Trial details
- NCT number
- NCT05007262
- Sponsor
- Guizhou Bailing Group Pharmaceutical Co Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2023-10-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.